- INO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $14.2 million.
- INO has traded 73,715 shares today.
- INO is up 3.6% today.
- INO was down 17.2% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in INO with the Ticky from Trade-Ideas. See the FREE profile for INO NOW at Trade-Ideas More details on INO: Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. Currently there are 6 analysts that rate Inovio Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Inovio Pharmaceuticals has been 1.0 million shares per day over the past 30 days. Inovio has a market cap of $589.8 million and is part of the health care sector and drugs industry. The stock has a beta of 3.56 and a short float of 22.7% with 7.78 days to cover. Shares are up 5.8% year-to-date as of the close of trading on Wednesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.